Tiruneh, Gizachew Tadele
Odwe, George
K’Oduol, Kezia
Gwaro, Hellen
Fesseha, Nebreed
Moraa, Zipporah
Haake Kamberos, Alexandra
Hasan, Mohamed Mosaad
Magge, Hema
Nisar, Yasir B
Hirschhorn, Lisa R
Funding for this research was provided by:
Bill & Melinda Gates Foundation (Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241, Investment Number INV-024241)
Article History
Received: 1 March 2024
Accepted: 10 September 2024
First Online: 21 September 2024
Declarations
:
: For the Ethiopia project, ethical clearance was obtained from the Ethiopian Public Health Association (EPHA) Research Ethics Review Committee (Reference #: EPHA/OG/166/21 dated April 16, 2021) and renewed for the end-line survey (Reference #: EPHA/OG/781/22 dated April 18, 2022). In Kenya, the study was approved by the Amref Ethics and Scientific Review Committee (as ESRC P949/2021) and the Population Council’s Institutional Review Board (as Protocol 968), while the National Commission for Science, Technology and Innovation (NACOSTI) granted the research permit. Northwestern University determined the project involved non-human subjects as no identifiable data was shared and the analyses involving the Northwestern University team leveraged existing, aggregate de-identified data. All study participants gave informed consent in both country projects.
: Not applicable as all figures were developed as part of the work.
: The authors declare no competing interests. YBN is staff member of the World Health Organization. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated.